Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹113 Cr₹109 Cr₹40 Cr₹31 Cr₹61 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹113 Cr based on Mar2026 Standalone results.
Year Revenue
Mar2026₹113 Cr
Mar2025₹109 Cr
Mar2024₹40 Cr
Mar2023₹31 Cr
Mar2022₹61 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2026 ₹113 Cr
3.37
Mar2025 ₹109 Cr
175.72
Mar2024 ₹40 Cr
27.93
Mar2023 ₹31 Cr
-48.80
Mar2022 ₹61 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹236.2 Cr -5.3% 32.3% -28.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-5.3%

32.3%

-28.1%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses